Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.
NEJM Highlights for May 2016: Referral for surgery, and a miscellany of interesting biochemistry
By
Marc Herant
NEJM
Read more
NEJM Highlights April 2016: Value and values: RBRVS, ACA and readmissions, E-cigs
By
Marc Herant
NEJM
Read more
NEJM Highlights March 2016: Getting value for money in healthcare, Zika bad news, linking the microbiome to the metabolic syndrome
By
Marc Herant
NEJM
Read more
NEJM Highlights Feb 2016: metrics for all, ROI perversion, less memory loss, the value of a kinder gentler residency
By
Marc Herant
NEJM
Read more
NEJM Highlights January 2016: a medley of social service, OB, data mining, obesity, and ESRD
By
Marc Herant
NEJM
Read more
NEJM Highlights December 2015: providing effective healthcare is hard and expensive – but ineffective care can be even more expensive – and defining what expensive means in healthcare is hard
By
Marc Herant
NEJM
Read more
NEJM Highlights November 2015: systems biology, RSV progress, a first in diabetes, hypertension goals, the case of Maryland
By
Marc Herant
NEJM
Read more
NEJM Highlights October 2015: what to do, how to do it, and to whom
By
Marc Herant
NEJM
Read more
Working paper: the coming age of algorithmic medicine
By
Marc Herant
Payers
,
Providers
,
Digital
,
Read more
NEJM Highlights September 2015: cells, cells, cells
By
Marc Herant
NEJM
Read more
NEJM Highlights August 2015: cancer and joints
By
Marc Herant
NEJM
Read more
NEJM Highlights July 2015: a first in class drug for cancer, Sovaldi cures renal failure too (sometimes), convenient primary care
By
Marc Herant
NEJM
Read more
NEJM Highlights for June 2015: the flavor of the month is distinctly cardiovascular
By
Marc Herant
NEJM
Read more
NEJM Highlights May 2015: a read on ACO performance, progress in cystic fibrosis treatment, yes developing new drugs is expensive, rethinking industry-medicine relationships, CVS Caremark and smoking cessation
By
Marc Herant
NEJM
Read more
NEJM Highlights April 2015
By
Marc Herant
NEJM
Read more
NEJM Highlights March 2015: Progress against Crohn’s, PCSK9 inhibitors coming through, comparative effectiveness for diabetic macular edema, Eric Lander encourages the FDA on genomic testing regulation
By
Marc Herant
NEJM
Read more
NEJM Highlights February 2015: the most boring month in my NEJM reading memory
By
Marc Herant
NEJM
Read more
NEJM Highlights January 2015: Dengue vaccine, Informed consent, Cancer drugs and Tiering for selection
